Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 1987-12-20 (38 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TOULOUSE (31500), Haute-Garonne
PHARMACIE JEAN CHAUBET : revenue, balance sheet and financial ratios
PHARMACIE JEAN CHAUBET is a French company
founded 38 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TOULOUSE (31500),
this company of category PME
shows in 2023 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JEAN CHAUBET (SIREN 344430863)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 828 242 €
1 838 126 €
1 634 820 €
1 424 230 €
N/C
N/C
N/C
N/C
Net income
117 025 €
318 306 €
120 067 €
197 062 €
141 499 €
35 952 €
28 558 €
846 €
52 880 €
27 858 €
EBITDA
N/C
N/C
163 101 €
268 108 €
205 200 €
94 095 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
6.6%
10.7%
8.7%
2.5%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE JEAN CHAUBET generates positive net income of 117 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 28 k€ -> 117 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
117 025 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 50%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
50.384%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
54.336%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE JEAN CHAUBET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
76.998
67.291
66.662
63.511
73.841
62.2
38.642
42.406
41.119
50.384
Financial autonomy
44.565
46.837
47.854
49.298
44.407
46.034
54.775
57.074
55.929
54.336
Repayment capacity
None
None
None
None
8.072
2.365
1.32
2.24
None
None
Cash flow / Revenue
None%
None%
None%
None%
3.14%
9.176%
11.185%
7.558%
None%
None%
Sector positioning
Debt ratio
50.382025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average+13 pts over 3 years
In 2025, the debt ratio of PHARMACIE JEAN CHAUBET (50.38) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
54.34%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good-10 pts over 3 years
In 2025, the financial autonomy of PHARMACIE JEAN CHAUBET (54.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
2.24 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Good
In 2023, the repayment capacity of PHARMACIE JEAN CHAUBET (2.24) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 217.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
217.689
Liquidity indicators evolution PHARMACIE JEAN CHAUBET
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
131.322
135.976
126.081
116.466
127.236
129.979
151.705
163.772
175.423
217.689
Interest coverage
None
None
None
None
4.323
3.038
1.571
4.549
None
None
Sector positioning
Liquidity ratio
217.692025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good+24 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE JEAN CHAUBET (217.69) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
4.55x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE JEAN CHAUBET (4.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 67 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 657 days. Excellent situation: suppliers finance 590 days of the operating cycle (retail model).
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
67 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
657 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE JEAN CHAUBET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
175 878 €
126 077 €
187 893 €
265 040 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
43
46
45
47
0
0
Customer payment term (days)
0
0
0
0
4
2
1
4
0
67
Supplier payment term (days)
0
0
0
0
64
59
55
52
0
657
Positioning of PHARMACIE JEAN CHAUBET in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE JEAN CHAUBET is estimated at
1 858 956 €
(range 1 261 496€ - 2 916 958€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1261k€1858k€2916k€
1 858 956 €Range: 1 261 496€ - 2 916 958€
NAF 5 année 2025
Valuation method used
Net Income Multiple
117 025 €
×
15.9x
=1 858 956 €
Range: 1 261 496€ - 2 916 958€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JEAN CHAUBET with other companies in the same sector:
Frequently asked questions about PHARMACIE JEAN CHAUBET
What is the revenue of PHARMACIE JEAN CHAUBET ?
The revenue of PHARMACIE JEAN CHAUBET in 2023 is 1.8 M€.
Is PHARMACIE JEAN CHAUBET profitable?
Yes, PHARMACIE JEAN CHAUBET generated a net profit of 117 k€ in 2025.
Where is the headquarters of PHARMACIE JEAN CHAUBET ?
The headquarters of PHARMACIE JEAN CHAUBET is located in TOULOUSE (31500), in the department Haute-Garonne.
Where to find the tax return of PHARMACIE JEAN CHAUBET ?
The tax return of PHARMACIE JEAN CHAUBET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JEAN CHAUBET operate?
PHARMACIE JEAN CHAUBET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart